Post Block HTML
We are honored to recognize the law firms and purpose-driven leaders who have not only navigated their...
Looking back at the past decade, in 2013, filings of patent lawsuits in the United States were at an...
Choice IP and The PCT Network join forces to create a new IP service provider: Azami Global [New York,...
Australia stands apart from many other key jurisdictions in allowing first and second medical use claims...
FibroGen Inc. v Akebia Therapeutics Inc. and another company; Astellas Pharma Inc. v Akebia Therapeutics...
When evaluating the novelty of claims in life sciences and pharmaceutical, compared with EPO, the examination...
The Canadian Patent Act imposes an unyielding relationship between the requirement for a written...
Prosecution pathway for pharma & bio patents in india – part 1 The Indian pharmaceutical industry,...
Considering the IP and Legal Implications of Gene Editing Global food security is increasingly challenging...
Korean practice is quite strict, with respect to requirements for claiming small molecules, which are...